carbamic acid has been researched along with Chronic Disease in 2 studies
carbamic acid : A one-carbon compound that is ammonia in which one of the hydrogens is replaced by a carboxy group. Although carbamic acid derivatives are common, carbamic acid itself has never been synthesised.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Excerpt | Relevance | Reference |
---|---|---|
"Cinacalcet hydrochloride was found to be cost effective only for those who cannot undergo parathyroidectomy." | 2.48 | [Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD]. ( Hamano, T, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joki, N | 1 |
Iwasaki, M | 1 |
Hamano, T | 1 |
2 reviews available for carbamic acid and Chronic Disease
Article | Year |
---|---|
[Kidney and bone update : the 5-year history and future of CKD-MBD. Vascular calcification in CKD patients].
Topics: Bone Diseases, Metabolic; Calcium; Carbamates; Chelating Agents; Chronic Disease; Disease Progressio | 2012 |
[Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD].
Topics: Bone Diseases, Metabolic; Carbamates; Chelating Agents; Chronic Disease; Cinacalcet; Cost-Benefit An | 2012 |